Clinical trial
Study of MK0476 (Montelukast Sodium) and Effects on Asthma and Nasal Symptoms…
NCT00092105 · Organon and Co, Industry · Completed
Key facts
| NCT number | NCT00092105 |
|---|---|
| Title | Study of MK0476 (Montelukast Sodium) and Effects on Asthma and Nasal Symptoms Upon Exposure to Cats (0476-256) |
| Official title | A Multicenter, Double-Blind, Randomized, Crossover Study Investigating the Clinical Effect of Montelukast in Patients With Concomitant Asthma and Allergic Rhinitis Upon Controlled Exposure to Cat Allergen |
| Lead sponsor | Organon and Co, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Asthma, Bronchial, Rhinitis, Allergic, Perennial |
| Intervention type | Drug |
| Interventions | MK0476, montelukast sodium, Comparator: placebo |
| Enrollment | 58 |
| Start date | Apr 1, 2002 |
| Primary completion | Jan 1, 2003 |
| Completion | Jan 28, 2003 |
| First posted | Sep 24, 2004 |
| Last update posted | Aug 14, 2024 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: